U.S. Food & drug administration (FDA) office of inspections and investigations (OII) biomanufacturing principles and processes training series

Open Pre-Solicitation Posted

Solicitation number
OII-2027-133938
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

PSC
Not on record
Place of performance
Silver Spring, Maryland, United States

Notice details come from SAM.gov. Updated .

About this opportunity

FDA's Office of Acquisition and Grant Services is conducting market research through a Sources Sought Notice for Biomanufacturing Principles and Processes Training services on behalf of the Office of Inspections and Investigations, with responses due December 1, 2027. The notice carries No Set-Aside Used and is for planning purposes only, not a commitment to solicit or award. The anticipated stand-alone contract would award a single contractor to develop and deliver a four-course series for FDA investigators covering Quality Control and Analytical Testing, Upstream Bioprocessing, Downstream Bioprocessing, and Aseptic Processing. Delivery is hybrid: asynchronous web-based learning on the BTEC Shorts platform, synchronous webinars, and hands-on laboratory training at the contractor's facility. Each course runs five weeks with 32 contact hours (8 online, 24 on-site over three days) and a maximum of 25 students per cohort, and must be completed within 12 months of award.

All contractor personnel require FDA security clearance at the Public Trust Position Level 5 before beginning work, with processing typically requiring four weeks. The contractor must not develop or manufacture FDA-regulated products and must have personnel experienced in biotechnology or pharmaceutical production and adult education. Materials must comply with Section 508, HTML5, SCORM conformance, and FDA IT security specifications.

The base year runs March 31, 2027 through March 30, 2028, with four one-year options and a potential six-month extension through September 2032 under FAR 52.217-8. The expected contract type is Firm-Fixed-Price. Enrollment for the first course must open within six months of award, web-based content within eight months, and in-person materials within ten months.

Respondents submit information through Attachment B, the Vendor Feedback Form, and review Attachment A, the Draft Statement of Work. The Government will not acknowledge receipt or provide feedback on submissions and reserves the right to contact respondents after the deadline. NAICS code is 611430.

Notice text

FOOD AND DRUG ADMINISTRATION (FDA)

OFFICE OF INSPECTIONS AND INVESTIGATIONS (OII)

BIOMANUFACTURING PRINCIPLES AND PROCESSES TRAINING SERIES

SOURCES SOUGHT NOTICE (SSN)

Description

The U.S. Food and Drug Administration's (FDA), Office of Acquisitions and Grants Services (OAGS), is conducting market research for obtaining Biomanufacturing Principles and Processes Training services.

THIS IS A SOURCES SOUGHT NOTICE (SSN) ONLY. This SSN is being issued in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. It is for information, planning and market research purposes only and is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. The Government reserves the right to contact any of the respondents after the submission deadline if additional information is required.

The purpose of this SSN is to identify and gain knowledge of potential business sources and small business sources that are capable of providing the full range of services described in this SSN and the attached Draft Statement of Work (SOW). Responses to this SSN will be utilized for a potential solicitation for an anticipated stand-alone contract for the Biomanufacturing Principles and Processes Training Program. The anticipated period of performance for this contract is March 2027 through March 2032 (base year, plus four (4) option years), with a potential 6-month extension of services pursuant to FAR 52.217-8, for a total potential period of performance through September 2032.

Requested Information

Interested parties are highly encouraged to respond to this SSN by providing the following information in their response:

  1. Completed Vendor Feedback Form – See attached Vendor Feedback Form
  2. If applicable, tracked changes/comments on draft SOW in MS Word format – See attached Draft SOW
  3. Capability Statement

Responses shall be submitted via email with the subject line "Sources Sought Notice - FDA SSN: OII-2027-133938” to the Contracting Officer, Nicholas Bisher (Nicholas.Bisher@fda.hhs.gov), no later than 12:00pm (Eastern) on December 1, 2026.

Attachments

  1. Vendor Feedback Form
  2. Draft Statement of Work

Files

File Type Posted
Attachment B - Vendor Feedback Form.docx DOCX document
Attachment A - Draft Statement of Work.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
FDA Scientific & Regulatory Support Services(SRS) Silver Spring, Maryland 20993, United States · NAICS 541990 FDA Office of Acquisition and Grant Services Total Small Business
U.S. Food and Drug Administration Regulatory Support Services BPA Silver Spring, Maryland, United States · NAICS 541611 FDA Office of Acquisition and Grant Services No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors